Evidence map›Paper›PMID 41402296›Full record

ArticleNature communications2025

3D-MINFLUX nanoscopy reveals distinct allosteric mechanisms for activation and modulation of PIEZO1 by Yoda1.

Clement Verkest, Lucas Roettger, Nadja Zeitzschel, Stefan G Lechner

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Yoda molecules agonize PIEZO2.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Clement VerkestDepartment of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-8612-8002
Lucas RoettgerDepartment of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0009-0009-6112-0915
Nadja ZeitzschelDepartment of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0003-4332-7049
Stefan G LechnerDepartment of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. s.lechner@uke.de.ORCID http://orcid.org/0000-0001-9402-9127

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) LE3210/3-3
6 · The paper itself

Abstract

The small molecule Yoda1 has become an indispensable tool for dissecting the role of the mechanically activated ion channel PIEZO1 in physiological and pathological contexts. Previous studies proposed that Yoda1 first binds to a hydrophobic pocket at the interface of the transmembrane helical units 8 and 9 close to the inner leaflet of the membrane to induce conformational flattening and thus channel activation and then transitions to a deeper located binding site with higher affinity in the open conformation. Here, using site-directed mutagenesis, electrophysiology, computational modelling and 3D-MINFLUX nanoscopy, we refine this model by demonstrating that mutation of the previously proposed Yoda1 binding site-I, solely abolishes Yoda1-induced activation and channel flattening but preserves modulation of mechanically-evoked PIEZO1 currents, whereas mutation of F1715, which lines a transient binding cavity accessible only in the flattened PIEZO1 conformation, eliminated modulation without affecting Yoda-induced calcium entry. Thus, our data support a revised model for Yoda's mode of action that distinguishes discrete allosteric pathways for PIEZO1 activation versus modulation and provides a framework for the design of next-generation use-dependent PIEZO1 modulators.

Indexed as

Ion ChannelsModels, MolecularAllosteric RegulationAllosteric SiteAnimalsCell LineMiceProtein ConformationPyrazinesThiadiazolesIon ChannelsPiezo1 protein, mousePyrazinesThiadiazolesyoda-1

Identifiers

PMID41402296
PMCPMC12712055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.